Controlled-release nitrogen fertilizer improved citrus production and reduced several types of nitrogen losses in a two-year ...

A new study in BMC Chemistry details the synthesis and characterization of two copper(II) Schiff base complexes, showing that one variant exhibits superior inhibitory activity against jack bean urease ...

A two-year field study in subtropical China shows that amending fertilizers with dual inhibitors and biochar cuts nitrous ...

The difference between 50°F and 55°F soil temps matters more than what you might realize. Here's what the research says about ...

The U.S. FDA on Wednesday approved AstraZeneca (AZN) subsidiary Alexion's Ultomiris to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression.

Oct 21 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment for adults with immunoglobulin A nephropathy, ...

Alexion, AstraZeneca Rare Disease’s ULTOMIRIS ® (ravulizumab-cwvz) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 20, 2026-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago ...

Tony Wood, Chief Scientific Officer, GSK, said: “Despite current therapies, many people living with chronic hepatitis B remain on treatment indefinitely and continue to face the risk of serious liver ...

NORTH CHICAGO, Ill., Oct. 17, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of 20 new scientific abstracts from its IBD portfolio at the 2026 United European ...

"This approval is the answer to a question on which we've been relentlessly focused: How do we continue to improve an already effective therapy for daily use?" said Kimberly Moran, PhD, SVP & Head, ...